吉西他滨
蛋白激酶B
癌症研究
PI3K/AKT/mTOR通路
药理学
化学
下调和上调
细胞凋亡
生物
癌症
医学
内科学
生物化学
基因
作者
Fei Song,Chenggui Wang,Tianlun Wang,Yi-Chao Tao,Jiazhen Mao,Chen-Wei Hu,Yu Zhang,Peng-Ju Tang,Changliang Lu,Huan-Long Qing,Lu Han,Zhong Chen
出处
期刊:Phytomedicine
[Elsevier]
日期:2024-08-08
卷期号:133: 155944-155944
被引量:9
标识
DOI:10.1016/j.phymed.2024.155944
摘要
Intrahepatic cholangiocarcinoma (ICC) remains a significant challenge in cancer therapy, especially due to its resistance to established treatments like Gemcitabine, necessitating novel therapeutic approaches.
科研通智能强力驱动
Strongly Powered by AbleSci AI